Reversal of tachycardiomyopathy by the atrial defibrillator

Mitchell, Andrew R.J.; Spurrell, Philip A.R.; Ahmet, Huseyin; Higson, Mike; Sulke, Neil

doi:10.1016/s1388-9842(02)00095-8

Search citation statements

Order By: Relevance

Paper Sections

Select...

Clinical Evaluation and Management1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2003

2009

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Weighing the risks and benefits in each individual patient must therefore individualize the rhythm versus rate control options. Use of the atrial defibrillator has been reported to revert tachycardia‐induced cardiomyopathy 95 . Tachycardia‐induced cardiomyopathy is a diagnosis of exclusion but should always be considered in patients with no other obvious explanation for LV dysfunction.…”

Section: Clinical Evaluation and Managementmentioning

confidence: 99%

Tachycardia‐Induced Cardiomyopathy: A Review of Literature

Khasnis

Jongnarangsin

Abela

et al. 2005

Pacing Clinical Electrophis

100

View full text Add to dashboard Cite

Section: Clinical Evaluation and Managementmentioning

confidence: 99%

Tachycardia‐Induced Cardiomyopathy: A Review of Literature

Khasnis

Jongnarangsin

Abela

et al. 2005

Pacing Clinical Electrophis

100

View full text Add to dashboard Cite

Electrophysiological characteristics associated with symptoms in pacemaker patients with paroxysmal atrial fibrillation

Silberbauer¹,

Veasey²,

Cheek

et al. 2009

J Interv Card Electrophysiol

View full text Add to dashboard Cite

show abstract

Untitled

Santini

Ricci

2003

Journal of Interventional Cardiac Electrophysiology

View full text Add to dashboard Cite

Dual defibrillator implantation represents an emerging option to treat patients with drug refractory atrial fibrillation. Atrial antitachycardia pacing and cardioversion have been demonstrated to be highly effective in treating spontaneous tachyarrhythmias and may reduce atrial fibrillation burden by preventing atrial remodeling. Device implantation has been associated to improved quality of life and reduced hospitalization rate. Patient selection and tailored device programming are critical as regard to clinical outcome. Individual psychological profile analysis as well as underlying heart disease and atrial fibrillation clinical patterns represent the main drivers for the right strategy. Controlled studies are needed in order to define the subset of patients who can benefit more from device implantation.

show abstract

Reversal of tachycardiomyopathy by the atrial defibrillator

Cited by 4 publications

References 11 publications

Tachycardia‐Induced Cardiomyopathy: A Review of Literature

Tachycardia‐Induced Cardiomyopathy: A Review of Literature

Electrophysiological characteristics associated with symptoms in pacemaker patients with paroxysmal atrial fibrillation

Untitled

Contact Info

Product

Resources

About